2025-12-31 - Analysis Report
Okay, here's a breakdown of the UNH stock analysis, followed by a comprehensive summary:

**1) Return Rate Comparison and Alpha/Beta Analysis**

*   **Company Overview:** UnitedHealth Group Inc (UNH) is a diversified healthcare company operating primarily in the United States.

*   **Return Rate Comparison:**
    *   UNH Cumulative Return: -17.22%
    *   VOO (S&P 500) Cumulative Return: 102.21%
    *   Divergence: -120.5
    *   Relative Divergence: 6.1

*   **Analysis:**
    *   UNH has significantly underperformed the S&P 500 (VOO) over the period examined. The -17.22% return compared to the S&P 500's 102.21% indicates substantial underperformance.  The Divergence of -120.5 reflects this large difference.
    *   The Relative Divergence of 6.1 suggests the current divergence is near the lower end of its historical range, implying the potential for future recovery relative to the S&P 500 (VOO), assuming past patterns hold.

*   **Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta  | Cap(B)  |
|------------|--------|--------|---------|-------|---------|
| 2015-2017  | 58.0%  | 66.4%  | 30.0%   | 0.1   | 199.7   |
| 2016-2018  | 41.0%  | 70.4%  | 26.0%   | 0.1   | 225.7   |
| 2017-2019  | 36.0%  | 73.8%  | 14.0%   | 0.2   | 266.3   |
| 2018-2020  | -43.0% | 81.2%  | -67.0%  | 0.5   | 317.7   |
| 2019-2021  | 16.0%  | 81.2%  | -30.0%  | 1.5   | 454.9   |
| 2020-2022  | -1.0%  | 81.2%  | 0.0%    | 1.5   | 480.3   |
| 2021-2023  | 24.0%  | 80.8%  | 23.0%   | 0.4   | 476.9   |
| 2022-2024  | -27.0% | 78.8%  | -47.0%  | 0.3   | 458.2   |
| 2023-2025  | -60.0% | 79.8%  | -126.0% | 1.2   | 300.9   |

*   **Analysis:**
    *   **CAGR:** The Compound Annual Growth Rate has fluctuated significantly, with strong growth in earlier periods (2015-2019) followed by periods of negative growth. The most recent period (2023-2025) shows a steep decline (-60%).
    *   **MDD:** The Maximum Drawdown is consistently high, indicating significant risk and volatility in UNH's returns.
    *   **Alpha:** Alpha, which measures outperformance relative to the market, is negative in the more recent periods, indicating underperformance. Notably, the 2023-2025 alpha is highly negative (-126%).
    *   **Beta:** Beta has increased over time, suggesting that UNH's price movements have become more correlated with the overall market. The Beta is volatile.
    *   **Cap(B):** Company capitalization has decreased.

**2) Recent Stock Price Fluctuations**

*   Current Price: 332.16
*   Previous Close: 328.94
*   Change: 0.98
*   5-day SMA: 329.06
*   20-day SMA: 331.05
*   60-day SMA: 337.99

*   **Analysis:**
    *   The stock is currently trading above its 5-day and 20-day Simple Moving Averages (SMA), suggesting a short-term upward trend.
    *   However, the price is below the 60-day SMA, indicating that the longer-term trend might still be downward or sideways.
    *   The small positive change from the previous close indicates a slight upward movement in the most recent trading session.

**3) RSI, PPO, and Market Risk Indicators**

*   Market Risk Indicator (MRI): 0.9 (High Investment Recommended)
*   RSI: 58.84
*   PPO: 0.06
*   Hybrid Signal: cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Dividend_2.21 (Cash Ratio: 0% on 2025-12-08)
*   Recent (20 days) relative divergence change: -1.9 (short-term decline)
*   Expected Return (%): -328.2%

*   **Analysis:**
    *   The MRI of 0.9 suggests that the market conditions are currently favorable for investment, according to this indicator.
    *   The RSI of 58.84 is neutral, neither overbought nor oversold.
    *   The PPO of 0.06 indicates that the shorter-term moving average is slightly above the longer-term moving average, suggesting a mild upward trend.
    *   The Hybrid Signal suggests a strong buy signal, although this should be considered with caution, given the other negative indicators.
    *   The recent decrease in relative divergence indicates a short-term decline.
    *   The expected return of -328.2% is extremely negative, indicating a very pessimistic outlook for future returns.

**4) Recent News & Significant Events**

*   **Key Themes:**
    *   **Risks and Pressures:** Multiple articles highlight risks and pressures facing UnitedHealth, including concerns about remote monitoring policies and potential fraud probes.
    *   **Comparison with Competitors:** At least one article directly compares UNH to a competitor (ELV), suggesting potential competitive pressures.
    *   **Valuation Debate:**  There's a mix of opinions, with some articles suggesting UNH is undervalued while others point to significant challenges.

*   **Specific Headlines & Links:**
    *   "3 Risks That Can Make UnitedHealth Stock Unattractive" - Signals caution regarding potential downsides.
    *   "UNH vs. ELV: Which Managed Care Stock Has the Edge Today?" -  Indicates a competitive landscape.
    *   "UnitedHealth (UNH) stock slips after hours as UnitedHealthcare delays remote monitoring policy" - Shows immediate market reaction to policy changes.
    *   "UnitedHealth: Undervalued Blue-Chip Stock With Multiple Levers To Pull & Ways To Win (UNH)" - Presents a more optimistic perspective.
    *   "UNH Stock Today: December 30 – Minnesota Fraud Probe Flags Medicaid Risk" - Highlights potential legal and financial risks.
    *    "Can UnitedHealth Stock Withstand These Pressures?" - Reinforces the theme of external challenges.

*   **Analysis:**
    *   The news sentiment is mixed, with a strong undercurrent of concern regarding risks, regulatory issues, and competitive pressures.  The negative headlines appear to outweigh the positive ones.

**4-2) Analyst Opinions**

*   **Consensus:**
    *   Rating: Buy (~1.96 on a 1-5 scale)
    *   Number of Opinions: 25
    *   Target Price: 392.24 (Avg), 440.00 (High), 280.00 (Low)
    *   Recent Rating Changes: Not specified.

*   **Analysis:**
    *   Analysts generally have a "Buy" rating on UNH with a significant number of opinions considered.
    *   The average target price of $392.24 suggests potential upside from the current price of $332.16. However, the wide range between the high and low target prices ($440 - $280) indicates considerable uncertainty among analysts. The low target price is very concerning.
    *   The lack of information on recent rating changes makes it difficult to assess the current trend in analyst sentiment.

**5) Recent Earnings Analysis**

| 날짜         | EPS   | 매출      |
|--------------|-------|-----------|
| 2025-10-28  | 2.59  | 113.16 B$ |
| 2025-08-11  | 3.76  | 111.62 B$ |
| 2025-05-07  | 6.9   | 109.58 B$ |
| 2024-11-04  | 6.56  | 100.82 B$ |
| 2025-10-28  | 6.56  | 100.82 B$ |

*   **Analysis:**
    *   Revenue has generally been increasing quarter over quarter, indicating sales growth.
    *   EPS (Earnings Per Share) has been volatile, with a recent decrease.
    * The duplication of "2025-10-28	6.56	100.82 B$" date raises questions about the data accuracy.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30  | $113.16B   | 18.24%        |
| 2025-06-30  | $111.62B   | 17.93%        |
| 2025-03-31  | $109.58B   | 21.70%        |
| 2024-12-31  | $100.81B   | 21.14%        |
| 2024-09-30  | $100.82B   | 22.84%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE   |
|--------------|------------|-------|
| 2025-09-30  | $95.79B   | 2.45% |
| 2025-06-30  | $94.72B   | 3.60% |
| 2025-03-31  | $95.04B   | 6.62% |
| 2024-12-31  | $92.66B   | 5.98% |
| 2024-09-30  | $94.53B   | 6.41% |

*   **Analysis:**
    *   Revenue has shown consistent growth over the past year.
    *   Profit margins have fluctuated.
    *   Equity has seen some increase.
    *   ROE (Return on Equity) has decreased, indicating that the company is generating less profit from shareholders' investments compared to previous quarters.

**7) Comprehensive Analysis (Summary)**

*   **Negative Performance:** UNH has significantly underperformed the S&P 500 in terms of cumulative return and has seen a sharp decline in CAGR and Alpha in recent periods.
*   **High Volatility:** The Maximum Drawdown is consistently high, indicating substantial risk.
*   **Mixed Signals:**
    *   Technical indicators like RSI and PPO are currently neutral to slightly positive.
    *   The Market Risk Indicator suggests a favorable investment environment, BUT this contradicts other data.
    *   Analyst consensus is "Buy," but target prices have a wide range, reflecting uncertainty.
*   **Concerning News:** Recent news highlights several risks and pressures facing the company, including regulatory scrutiny and competitive challenges.
*   **Decreasing ROE**: Return on Equity has been decreasing
*   **Financial Performance:** Revenue is increasing, but profit margins and EPS are volatile.
*   **Overall:** Based on the provided data, UNH appears to be facing significant challenges. The stock has underperformed the market, and there are several risk factors to consider. While analysts have a "Buy" rating, the wide range in target prices reflects uncertainty.

**In conclusion, the analysis suggests that investing in UNH at this time may be risky. A cautious approach is warranted, and investors should carefully consider all the available information before making a decision.**


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.